New COPD drug trial aims to ease breathing and reduce lung inflammation
Disease control
Recruiting now
This study tests a new medicine, solrikitug, in people with chronic obstructive pulmonary disease (COPD). The goal is to see if it can safely lower certain immune cells (eosinophils) and improve lung function. About 171 adults aged 40–75 with moderate-to-severe COPD will receive …
Phase: PHASE2 • Sponsor: Uniquity One (UNI) • Aim: Disease control
Last updated May 14, 2026 12:02 UTC